Keywords: oncolytics, takes, reolysin, into, ph, ii, canada

Oncolytics takes Reolysin into Ph II

Article | 08 September 2008

Canada's Oncolytics Biotech is initiating a US Phase II clinical trial using intravenous administration of Reolysin (human reovirus) in patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Carboplatin

Paraplatin

Paclitaxel

Taxol

Go to drug listing